Overview
Medtronic's Neuromodulation division is a global leader in deep brain stimulation (DBS), spinal cord stimulation, and targeted drug delivery for conditions including Parkinson's disease, essential tremor, chronic pain, and epilepsy. Their Percept PC DBS system with BrainSense technology enables real-time neural sensing during therapy delivery.
More in Neuromodulation
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Category
⚡ Neuromodulation
Location
Dublin, Ireland
Funding
NYSE: MDT
Listed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →